Literature DB >> 3171333

The potential role of adenosine in regulating blood flow in the eye.

S C Braunagel1, J G Xiao, G C Chiou.   

Abstract

Blood flow in the eye has shown a remarkable ability to autoregulate regardless of intraocular pressure, perfusion pressure or alterations in arterial pressure. This study investigates the possibility that adenosine may play a role in regulating ocular blood flow. Ocular blood flow was measured using radio-labelled 85Sr microsphere and laser Doppler techniques. When two adenosine uptake inhibitors, dipyridamole and papaverine were injected intravitreally, the ocular blood flow increased in all ocular tissues tested: iris, iris root-ciliary body, retina and choroid. This increase in blood flow was blocked by the addition of the adenosine antagonist, 8-phenyltheophylline. The increase in flow produced by dipyridamole continued for up to an hour after administration. The increase in blood flow in individual ocular tissues does not appear to be due to shunting (ie. redistribution) of flow because total blood flow to the eye increased but the percent total flow to each individual tissue remained near control values.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3171333     DOI: 10.1089/jop.1988.4.61

Source DB:  PubMed          Journal:  J Ocul Pharmacol        ISSN: 8756-3320


  9 in total

1.  Multiple effects of adenosine in the arterially perfused mammalian eye. Possible mechanisms for the neuroprotective function of adenosine in the retina.

Authors:  Claudio Macaluso; Laura J Frishman; Beatrice Frueh; Alain Kaelin-Lang; Shoken Onoe; Günter Niemeyer
Journal:  Doc Ophthalmol       Date:  2003-01       Impact factor: 2.379

2.  Alterations of Ocular Hemodynamics Impair Ophthalmic Vascular and Neuroretinal Function.

Authors:  Shu-Huai Tsai; Wankun Xie; Min Zhao; Robert H Rosa; Travis W Hein; Lih Kuo
Journal:  Am J Pathol       Date:  2018-01-05       Impact factor: 4.307

3.  [Functional significance of adenosine receptors in the eye and their dysregulation in pseudoexfoliation syndrome].

Authors:  U Schlötzer-Schrehardt; M Zenkel; C Hofmann-Rummelt; F E Kruse; G O Naumann
Journal:  Ophthalmologe       Date:  2005-11       Impact factor: 1.059

4.  Adenosine A2A receptor mediated protective effect of 2-(6-cyano-1-hexyn-1-yl)adenosine on retinal ischaemia/reperfusion damage in rats.

Authors:  T Konno; A Sato; T Uchibori; A Nagai; K Kogi; N Nakahata
Journal:  Br J Ophthalmol       Date:  2006-04-13       Impact factor: 4.638

5.  Evaluation of IBMX-enhanced ocular hypotension after adrenergic agonists in the rabbit eye.

Authors:  M J Busch; P F Hoyng
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1995-05       Impact factor: 3.117

6.  Vasodilator effects of adenosine on retinal arterioles in streptozotocin-induced diabetic rats.

Authors:  Taisuke Nakazawa; Asami Mori; Maki Saito; Kenji Sakamoto; Tsutomu Nakahara; Kunio Ishii
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-12-19       Impact factor: 3.000

7.  Divergent roles of nitric oxide and rho kinase in vasomotor regulation of human retinal arterioles.

Authors:  Travis W Hein; Robert H Rosa; Zhaoxu Yuan; Elizabeth Roberts; Lih Kuo
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-10-22       Impact factor: 4.799

8.  Pterygium: nonsurgical treatment using topical dipyridamole - a case report.

Authors:  Beth H Carlock; Carol A Bienstock; Moshe Rogosnitzky
Journal:  Case Rep Ophthalmol       Date:  2014-03-25

Review 9.  Ocular Applications of Dipyridamole: A Review of Indications and Routes of Administration.

Authors:  Moshe Rogosnitzky; Itzhak Isakov; Wjatschesslaw Wlassoff; April Ingram; Y Robert Barishak
Journal:  J Ocul Pharmacol Ther       Date:  2015-12-22       Impact factor: 2.671

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.